ANRO
Alto Neuroscience is a biotechnology company focused on neuropsychiatry, leveraging brain biology to develop personalized medicines for psychiatric conditions. The company emphasizes precision approaches to predict clinical response and identify patients most likely to benefit from its drug candidates, with an initial focus on major depressive disorder, bipolar depression, and schizophrenia. Based in Mountain View, California, Alto combines deep neurobiology research with a clinical-stage pipeline to disrupt traditional trial-and-error treatment in psychiatry.
No recent news for this company.
No recent deals for this company.